Get started

Pharmasector

SYNCOMF FOR 3-6 MONTHSFor 3-6 Months Fundamentally, > Revenue Growth over 60% Quarterly > Net Income Growth over 70% Quarterly > EPS over 40% Yearly Technically, > Trading at the point of historically tested demand zone. > Rising relative strength. > Market Profile also suggesting an upmove. > Current levels suggests buyer's entry with volumes. Risk to Reward is 1:2.5 or more Profit Targets: 22-28, Can book some profits at first target and then trail SL further. Stop Loss: Below the current support, 19
NSE:SYNCOMFLong
by madhubansal
Pharma Sector Shines Amidst Market WeaknessOn December 19, 2024, the pharmaceutical sector in India experienced a notable uptrend, with the Nifty Pharma index rising over 1.8%, making it the only sector to gain in an otherwise weak market. The significant surge in delivery volume indicates a substantial influx of foreign capital into the sector. ◉ Several factors contributed to this positive movement: 1. Defensive Nature of the Sector: Amidst economic uncertainties, investors often turn to defensive sectors like pharma, which offer relatively lower risk compared to cyclical sectors. 2. Positive Market Sentiment: The overall sentiment for the pharma sector was buoyed by expectations of strong growth in the Indian pharmaceutical market, projected to reach $130 billion by 2030 and $450 billion by 2047. 3. Resilient to US Tariffs: India is a major supplier of generic drugs to the US, which could help shield this sector from tariffs due to its critical role in healthcare and the ongoing demand for affordable medications. ◉ Specific Stock Performances: 1. Ipca Laboratories NSE:IPCALAB : Up 5.4% ➖ The stock has formed a Bullish Pole & Flag pattern, and following a breakout, it is set to continue its upward movement. 2. Dr. Reddy's Laboratories NSE:DRREDDY : Up 4.3% ➖ The price has broken out of a falling trendline, signalling strong bullish momentum. ➖ This breakout, supported by a significant rise in trading volume, indicates growing investor interest. 3. Abbott India NSE:ABBOTINDIA : Up 3.4% ➖ The stock is currently in a consolidation phase within a parallel channel. ➖ After rebounding from the lower boundary, the price is now on an upward trend. ◉ Conclusion The Pharma sector's strong performance is driven by key players' impressive gains, contrasting with the broader market's decline. This divergence makes the sector an attractive investment opportunity. With a promising outlook and strong fundamentals, the Pharma sector is well-positioned for continued growth.
NSE:CNXPHARMALong
by GoodluckCapital
ERIS Lifesciences for 25% gainsDate: 3 Dec’24 Symbol: ERIS Timeframe: Weekly ERIS Lifesciences currently seems to be in Wave V of 3 which is heading towards 1960-70 (25% from current price of 1470) as seen in the chart. Wave 4 could then correct back to 1300 levels. The company, in the recently announced September quarter results has posted best ever revenues and operating profits. This is not a prediction but a possible wave count. This is also not a recommendation to trade or invest. Please do your own analysis. HINGLISH VERSION ERIS Lifesciences vartamaan mein Wave 3 ki V mein dikh rahee hai jo 1960-70 (vartamaan keemat 1470 se 25%) kee taraf badh rahee hai jaisa ki chart mein dekh sakte hain. Wave 4 phir 1300 ke star tak neeche aa sakta hai. Company ne haal hee mein ghoshit September quarter results mein ab tak ka sabse achchha revenue aur operating profit darj kiya hai. Yah koi prediction nahin balki sambhaavit Wave count hai. Yah trade lene ya invest karne ki bhi salaah nahi hai. Kripya apana vishleshan khud karein.
NSE:ERISLong
by DhandhaPaani
WANBURY LTD: 17-Year Resistance Shattered! Is This Pharma Stock WANBURY LTD: Breaking Resistance Like It's Going Out of Style! Technical Analysis: Breakout: Hold onto your hats, folks! Wanbury just smashed through a 17-year resistance level like a bull in a china shop... if the china shop had been reinforced for 17 years! Trend: The stock is in a strong uptrend, climbing faster than a squirrel on an espresso-coated tree. Volume: Huge volume activity observed. Traders are piling in like it's Black Friday at a discount pharmacy! Candle Pattern: That breakout candle is so bullish, it's practically wearing horns and pawing the ground. Support Levels: Previous resistance at 173.68 now likely to act as support. It's like the floor just became the ceiling, and Wanbury is redecorating the whole house! Fundamental Factors: Pharmaceutical sector seeing increased interest. Wanbury's producing more buzz than a beehive in a coffee shop. Potential new product launches or regulatory approvals could be fueling the rally. Risks: After such a strong move, a pullback is possible. Even rockets need to refuel sometimes! Keep an eye on broader market sentiment and sector-specific news. Trade Idea: Consider long positions with a stop loss below the breakout level. Target the psychological 200 level - it's time for Wanbury to join the 200 club! Remember, traders, timing is everything. You don't want to be fashionably late to this 17-year breakout party! Key Levels to Watch: Resistance turned support: 173.68 Next psychological resistance: 200.00 Stop loss consideration: Below 170.00 Disclaimer: This analysis is for educational purposes only. Always do your own research and manage your risk. Remember, the stock market is like a rollercoaster - thrilling, but it helps to have a strong stomach and know when to exit!
NSE:WANBURYLong
by TRADING-NASA
Symmetrical Triangle Breakout and pull back pattern seenHello Traders and Investors, i hope you all will be doing good. I have seen symmetrical breakout in SunPharma so publishing this..you can take advantage with that. Guy's Sun Pharma is looking good on chart, as it has given a breakout of kind of symmetrical triangle pattern and today price has make a pull back pattern which is going to retest the levels. Price is above 200-EMA which is positive sign for this and MACD also giving bullish crossover.. there is higher chances that we can see this above 1200 in coming few days. So for triangle pattern i already have explained earlier in other stocks. I will add below for your reference. Go and check about this pattern. Important levels for Sun Pharma:- Take from now cmp 1144 Keep stop loss at 1121 Targets we can see in upside 1186/1211++ Let's focus on about company:- Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India. Market Cap ₹ 2,74,508 Cr. Current Price ₹ 1,144 High / Low ₹ 1,170 / 922 Stock P/E 31.1 Book Value ₹ 233 Dividend Yield 1.00 % ROCE 16.4 % ROE 16.6 % Face Value ₹ 1.00 Debt ₹ 6,886 Cr. EPS ₹ 35.2 PEG Ratio 1.18 Promoter holding 54.5 % Intrinsic Value ₹ 518 Pledged percentage 2.29 % EVEBITDA 21.3 PROS Company has delivered good profit growth of 26.4% CAGR over last 5 years Company has been maintaining a healthy dividend payout of 56.0% CONS The company has delivered a poor sales growth of 10.6% over past five years. Tax rate seems low Company has a low return on equity of 14.0% over last 3 years. Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou
NSE:SUNPHARMALong
by TraderRahulPal